114 related articles for article (PubMed ID: 20178042)
1. The use of dyslipidemic hamsters to evaluate drug-induced alterations in reverse cholesterol transport.
Briand F
Curr Opin Investig Drugs; 2010 Mar; 11(3):289-97. PubMed ID: 20178042
[TBL] [Abstract][Full Text] [Related]
2. Diet-induced dyslipidemia impairs reverse cholesterol transport in hamsters.
Tréguier M; Briand F; Boubacar A; André A; Magot T; Nguyen P; Krempf M; Sulpice T; Ouguerram K
Eur J Clin Invest; 2011 Sep; 41(9):921-8. PubMed ID: 21299553
[TBL] [Abstract][Full Text] [Related]
3. Anacetrapib and dalcetrapib differentially alters HDL metabolism and macrophage-to-feces reverse cholesterol transport at similar levels of CETP inhibition in hamsters.
Briand F; Thieblemont Q; Muzotte E; Burr N; Urbain I; Sulpice T; Johns DG
Eur J Pharmacol; 2014 Oct; 740():135-43. PubMed ID: 25008069
[TBL] [Abstract][Full Text] [Related]
4. Anacetrapib promotes reverse cholesterol transport and bulk cholesterol excretion in Syrian golden hamsters.
Castro-Perez J; Briand F; Gagen K; Wang SP; Chen Y; McLaren DG; Shah V; Vreeken RJ; Hankemeier T; Sulpice T; Roddy TP; Hubbard BK; Johns DG
J Lipid Res; 2011 Nov; 52(11):1965-73. PubMed ID: 21841206
[TBL] [Abstract][Full Text] [Related]
5. Upregulating reverse cholesterol transport with cholesteryl ester transfer protein inhibition requires combination with the LDL-lowering drug berberine in dyslipidemic hamsters.
Briand F; Thieblemont Q; Muzotte E; Sulpice T
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):13-23. PubMed ID: 23139291
[TBL] [Abstract][Full Text] [Related]
6. Expression of cholesteryl ester transfer protein in mice promotes macrophage reverse cholesterol transport.
Tanigawa H; Billheimer JT; Tohyama J; Zhang Y; Rothblat G; Rader DJ
Circulation; 2007 Sep; 116(11):1267-73. PubMed ID: 17709636
[TBL] [Abstract][Full Text] [Related]
7. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.
Briand F; Tréguier M; André A; Grillot D; Issandou M; Ouguerram K; Sulpice T
J Lipid Res; 2010 Apr; 51(4):763-70. PubMed ID: 19965597
[TBL] [Abstract][Full Text] [Related]
8. Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport.
El Khoury P; Waldmann E; Huby T; Gall J; Couvert P; Lacorte JM; Chapman J; Frisdal E; Lesnik P; Parhofer KG; Le Goff W; Guerin M
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):285-94. PubMed ID: 26681758
[TBL] [Abstract][Full Text] [Related]
9. [HDL and reverse cholesterol transport. Role of cholesterol ester transfer protein].
Lagrost L; Gambert P
C R Seances Soc Biol Fil; 1992; 186(4):405-13. PubMed ID: 1301229
[TBL] [Abstract][Full Text] [Related]
10. Ezetimibe enhances macrophage reverse cholesterol transport in hamsters: contribution of hepato-biliary pathway.
Uto-Kondo H; Ayaori M; Sotherden GM; Nakaya K; Sasaki M; Yogo M; Komatsu T; Takiguchi S; Yakushiji E; Ogura M; Nishida T; Endo Y; Ikewaki K
Biochim Biophys Acta; 2014 Sep; 1841(9):1247-55. PubMed ID: 24989153
[TBL] [Abstract][Full Text] [Related]
11. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis.
Klerkx AH; El Harchaoui K; van der Steeg WA; Boekholdt SM; Stroes ES; Kastelein JJ; Kuivenhoven JA
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):706-15. PubMed ID: 16439711
[TBL] [Abstract][Full Text] [Related]
12. Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE*3Leiden.CETP mice.
van der Hoorn JW; de Haan W; Berbée JF; Havekes LM; Jukema JW; Rensen PC; Princen HM
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2016-22. PubMed ID: 18669886
[TBL] [Abstract][Full Text] [Related]
13. Reverse cholesterol transport and atherosclerosis. A mini review.
Cucuianu M; Coca M; Hâncu N
Rom J Intern Med; 2007; 45(1):17-27. PubMed ID: 17966439
[TBL] [Abstract][Full Text] [Related]
14. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
[TBL] [Abstract][Full Text] [Related]
15. In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.
Wang SP; Daniels E; Chen Y; Castro-Perez J; Zhou H; Akinsanya KO; Previs SF; Roddy TP; Johns DG
J Lipid Res; 2013 Oct; 54(10):2858-65. PubMed ID: 23898048
[TBL] [Abstract][Full Text] [Related]
16. An overview of reverse cholesterol transport.
Tall AR
Eur Heart J; 1998 Feb; 19 Suppl A():A31-5. PubMed ID: 9519340
[TBL] [Abstract][Full Text] [Related]
17. Important role for bone marrow-derived cholesteryl ester transfer protein in lipoprotein cholesterol redistribution and atherosclerotic lesion development in LDL receptor knockout mice.
Van Eck M; Ye D; Hildebrand RB; Kar Kruijt J; de Haan W; Hoekstra M; Rensen PC; Ehnholm C; Jauhiainen M; Van Berkel TJ
Circ Res; 2007 Mar; 100(5):678-85. PubMed ID: 17293475
[TBL] [Abstract][Full Text] [Related]
18. Selective uptake of high density lipoproteins cholesteryl ester in the dog, a species lacking in cholesteryl ester transfer protein activity; An in vivo approach using stable isotopes.
Ouguerram K; Nguyen P; Krempf M; Pouteau E; Briand F; Bailhache E; Magot T
Comp Biochem Physiol B Biochem Mol Biol; 2004 Aug; 138(4):339-45. PubMed ID: 15325333
[TBL] [Abstract][Full Text] [Related]
19. Anacetrapib and dalcetrapib: two novel cholesteryl ester transfer protein inhibitors.
Miyares MA
Ann Pharmacother; 2011 Jan; 45(1):84-94. PubMed ID: 21205945
[TBL] [Abstract][Full Text] [Related]
20. Effect of inhibiting cholesteryl ester transfer protein on the kinetics of high-density lipoprotein cholesteryl ester transport in plasma: in vivo studies in rabbits.
Kee P; Caiazza D; Rye KA; Barrett PH; Morehouse LA; Barter PJ
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):884-90. PubMed ID: 16373610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]